Results 101 to 110 of about 22,744 (213)

Expanding the Immunologic and Neuronal Landscape of IgE‐Mediated Anaphylaxis

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Anaphylaxis is a life‐threatening immunoglobulin E (IgE)‐mediated type I hypersensitivity reaction with rising prevalence and burden. It involves mast cell degranulation upon cross‐linking of antigen on mast cell‐bound IgE. Mechanisms of IgE‐mediated anaphylaxis remain incompletely understood, particularly the induction of systemic symptoms ...
Ruchi Biswas   +2 more
wiley   +1 more source

A Case of Post‐Transplantation Lymphoproliferative Disorder Following Kidney Transplantation

open access: yesCase Reports in Nephrology, Volume 2026, Issue 1, 2026.
This was a case of a 65‐year‐old gentleman known to have diabetes mellitus and hypertension since 2012 and post renal transplantation in 2016. He had also been treated for hepatitis C infection in the past. His regular medications included nebivolol 5 mg once a day, tacrolimus 4 mg twice a day, mycophenolate mofetil 500 mg twice a day, prednisolone 5 ...
Punam Ajay Raval   +4 more
wiley   +1 more source

The Role of Akt2 and CA-125 Serum Levels as Predictors for Successful Cytoreduction in Epithelial Ovarian Cancer Surgery [PDF]

open access: diamond, 2020
Yudi Mulyana Hidayat   +97 more
openalex   +1 more source

Impact of tumor cytoreduction in metastatic prostate cancer

open access: yesResearch and Reports in Urology, 2019
Yaya Sow, Ousmane Sow, Boubacar Fall, Babacar Sine, Alioune Sarr, Cyrille Zé Ondo, Babacar Diao, Alain Khassim Ndoye, Mamadou BaUrology and Andrology Department at Aristide Le Dantec Hospital, Cheikh Anta Diop University, Dakar, SenegalObjective ...
Sow Y   +8 more
doaj  

Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2014
Objective: This study aimed to identify features on preoperative computed tomography (CT) scans that are predictive of suboptimal primary cytoreduction and to evaluate the correlation between CT findings and intraoperative findings in advanced ovarian ...
Ha-Jeong Kim   +6 more
doaj   +1 more source

Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective study [PDF]

open access: yes, 2014
BACKGROUND: Salvage cytoreductive surgery (SCR) has been shown to improve the survival of cancer patients. This study aimed to determine the survival benefits of SCR for recurrent endometrial cancer in Chinese population.
Boer Shan   +3 more
core   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Lingying Wu   +56 more
wiley   +1 more source

ESTIMATION OF SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN CANCER – ABSTRACT OF THE RESEARCH PROJECT

open access: yesZdravniški Vestnik, 2018
Background: Morbidity and mortality caused by cancer persist to be an important health problem world- wide and in the European Union member states as well.
Špela Smrkolj   +6 more
doaj   +1 more source

Optimizing the primary treatment of patients with advanced ovarian cancer

open access: yesОпухоли женской репродуктивной системы, 2016
In this article we analyzed the issues of optimizing the upfront debulking surgery for patients with advanced ovarian cancer. We reviewed the recent evidence highlighting the actual concerns of using neoadjuvant chemotherapy aiming to reduce the tumor ...
S. O. Nikogosyan   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy